...
首页> 外文期刊>Green chemistry >Increasing the sustainability of membrane processes through cascade approach and solvent recovery—pharmaceutical purification case study
【24h】

Increasing the sustainability of membrane processes through cascade approach and solvent recovery—pharmaceutical purification case study

机译:通过级联方法和溶剂回收提高膜工艺的可持续性—药物纯化案例研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Membrane processes suffer limitations such as low product yield and high solvent consumption, hindering their widespread application in the pharmaceutical and fine chemicals industries. In the present work, the authors propose an efficient purification methodology employing a two-stage cascade configuration coupled to an adsorptive solvent recovery unit, which addresses the two limitations: The process has been validated on purification of active pharmaceutical ingredient (API) from genotoxic impurity (GTI) using organic solvent nanofiltration (OSN). The model system selected for study comprises roxithromycin macrolide antibiotic (Roxi) with 4-dimethylaminopyridine (DMAP) and ethyl tosylate (EtTS). as API and GTIs, respectively. By implementing a two-stage cascade configuration for membrane diafiltration, the process yield was increased from 58% to 95% while maintaining less than 5 ppm GTI in the final solution. Through this yield enhancement, the membrane process has been "revamped" from an unfeasible process to a highly competitive unit operation when compared to other traditional processes. The advantage of size exclusion membranes over other separation techniques has been illustrated by the simultaneous removal of two GTIs from different chemical classes. In addition, a solvent recovery step has been assessed using charcoal as a non-selective adsorbent, and it has been shown that pure solvent can be recovered from the permeate. Considering the costs of solvent, charcoal, and waste disposal, it was concluded that 70% solvent recovery is the cost-optimum point. Conventional single-stage diafiltration (SSD) and two-stage diafiltration (TSD) configurations were compared in terms of green metrics such as cost, mass and solvent intensity, and energy consumption. It was calculated that implementation of TSD, depending on the batch scale, can achieve up to 92% cost saving while reducing the mass and solvent intensity up to 73%. In addition, the advantage of adsorptive solvent recovery has been assessed revealing up to 96% energy reduction compared to distillation and a 70% reduction of CO2 footprint.
机译:膜工艺存在局限性,例如产品收率低和溶剂消耗高,阻碍了它们在制药和精细化工行业中的广泛应用。在当前的工作中,作者提出了一种有效的纯化方法,该方法采用两级联构结构与吸附性溶剂回收单元相结合,解决了两个局限性:该方法已经过从遗传毒性杂质中纯化活性药物成分(API)的验证。 (GTI)使用有机溶剂纳滤(OSN)。选择用于研究的模型系统包括具有4-二甲基氨基吡啶(DMAP)和甲苯磺酸乙酯(EtTS)的罗红霉素大环内酯抗生素(Roxi)。分别作为API和GTI。通过实现膜渗滤的两阶段级联配置,工艺收率从58%提高到95%,同时最终溶液中的GTI保持低于5 ppm。通过提高产量,与其他传统工艺相比,膜工艺已从不可行的工艺“重塑”为竞争激烈的单元操作。尺寸排阻膜相对于其他分离技术的优势已通过同时去除两种不同化学类别的GTI加以说明。另外,已经评估了使用木炭作为非选择性吸附剂的溶剂回收步骤,并且显示出可以从渗透物中回收纯溶剂。考虑到溶剂,木炭和废物处理的成本,得出的结论是70%的溶剂回收率是成本最佳点。根据绿色指标(例如成本,质量和溶剂强度以及能耗)比较了常规的单级渗滤(SSD)和两级渗滤(TSD)配置。据计算,根据批次规模,TSD的实施可以节省多达92%的成本,同时减少质量和溶剂强度的多达73%。此外,已评估了吸附性溶剂回收的优势,与蒸馏相比,其能源消耗降低了96%,二氧化碳足迹减少了70%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号